MED13L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.711800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.910020E-01
Normal-vs-Stage2
3.135700E-02
Normal-vs-Stage3
4.529700E-02
Normal-vs-Stage4
4.579200E-01
Stage1-vs-Stage2
6.789200E-01
Stage1-vs-Stage3
9.848400E-02
Stage1-vs-Stage4
5.013600E-01
Stage2-vs-Stage3
1.627160E-01
Stage2-vs-Stage4
2.623200E-01
Stage3-vs-Stage4
3.674300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.152000E-02
Normal-vs-AfricanAmerican
5.787000E-01
Normal-vs-Asian
7.457700E-03
Caucasian-vs-AfricanAmerican
1.005810E-01
Caucasian-vs-Asian
5.299700E-02
AfricanAmerican-vs-Asian
1.122630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.485900E-02
Normal-vs-Female
2.833800E-02
Male-vs-Female
9.168000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.164000E-01
Normal-vs-Age(41-60Yrs)
1.085580E-01
Normal-vs-Age(61-80Yrs)
1.848360E-02
Normal-vs-Age(81-100Yrs)
1.190190E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.996600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.540600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.820400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.283500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.310200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.028040E-02
Normal-vs-Daily Drinker
2.983800E-03
Normal-vs-Weekly Drinker
2.918200E-02
Normal-vs-Occasional Drinker
7.512200E-02
Normal-vs-Social Drinker
2.275600E-01
Non Drinker-vs-Daily Drinker
3.229600E-01
Non Drinker-vs-Weekly Drinker
9.904800E-01
Non Drinker-vs-Occasional Drinker
2.223200E-01
Non Drinker-vs-Social Drinker
1.163420E-01
Daily Drinker-vs-Weekly Drinker
4.042800E-01
Daily Drinker-vs-Occasional Drinker
4.403800E-02
Daily Drinker-vs-Social Drinker
5.126100E-02
Weekly Drinker-vs-Occasional Drinker
3.242600E-01
Weekly Drinker-vs-Social Drinker
2.180000E-01
Occasional Drinker-vs-Social Drinker
6.384800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.841370E-01
Normal-vs-Grade 2
9.727900E-02
Normal-vs-Grade 3
6.194200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.166000E-01
Grade 1-vs-Grade 3
6.318600E-01
Grade 1-vs-Grade 4
1.841370E-01
Grade 2-vs-Grade 3
5.940400E-01
Grade 2-vs-Grade 4
9.727900E-02
Grade 3-vs-Grade 4
6.194200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.492030E-02
Normal-vs-NonDiabetic
1.215640E-02
Diabetic-vs-NonDiabetic
9.024800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.930330E-02
Normal-vs-NoPancreatitis
1.576050E-02
Pancreatitis-vs-NoPancreatitis
4.189800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.654200E-02
Normal-vs-N1
3.326000E-02
N0-vs-N1
6.258000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.332300E-02
Normal-vs-TP53-NonMutant
1.722150E-01
TP53-Mutant-vs-TP53-NonMutant
9.366400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
